the invention of the ophthalmoscope in 1851 the causes of this disturbance could be described? Leibreich, 4 in 1859, was the first to describe 'albuminuric retinitis' in Bright's disease. However, it was not until 1914, after the invention of the Riva Rocci sphygmomanometer at the end of the nine teenth century, that Volhard and Fahr6 related the retinopathy to arterial hypertension.
It was then realised that the fundal appearance was associated with the severity of the hypertension and with the prognosis of the patient. In 1939 Keith et aC drew up a four-group grading system. Grade 3 (more recently called accelerated hypertensionS) consisted of 'angiospastic retinitis', 'characterised especially by oedema, cotton wool patches, and haemorrhages in the retina superimposed on a combination of sclerotic and spastic lesions in the arterioles'. Grade 4 (malignant hypertension) had the same picture with disc oedema. This group of patients had the worse prognosis, with 79% dead within 1 year and only 1 % surviving at 5 years. This classification is still used 9 but more recently it has been found that there is little difference in the survival of patients with grade 3 or 4 hypertensive retinopathy.lO· 1 1 It has therefore been proposed that the two stages be classified together and called accelerated hypertension. 1 2 ,13 The prognosis for patients with accelerated hyper tension has greatly improved with the advent of effective hypertensive treatment. 1 4, 1 5 However, the condition is still serious. The 10 year survival of such patients was reported as 48% in a paper published in 1986,11 but many centres now have 5 year survival data of 80%? with a worse prognosis in patients with renal failure. With treatment, the damaging effect of hypertension is greatly reduced, but it is not all reversed. 1 6 Retinopathy and disc swelling usually disappear within 6-12 months of the onset of antihypertensive therapyP However, retinal and optic nerve function may not return to normal Eye (1996) 10,321-327 © 1996 Royal College of Ophthalmologists because of infarction. 1 k Little has been written on the long-term effects of hypertension on ocular function. With increased survivaL studies on this aspect are now appropriate.
The effects of hypertension on the eye can be divided into hypertensive retinopathy, choroidopa thy and neuropathy. 19 . 2 0 There has been debate about whether disc swelling in accelerated hyperten sion is due to raised intracranial pressure or to ischaemia. 21 We felt electrophysiological measure ments would be useful to examine these processes and are not aware that this has been done before.
SUBJECTS AND METHODS
A total of 34 patients with accelerated hypertension were studied: 20 males, 14 females (age range years, mean age 47.5 years). These patients were referred to the authors over an 8 year period for the management of accelerated hypertension. The patients were studied prospectively; however, not all the patients had electrophysiological tests acutely as will be explained. The diagnosis was made on finding grade III or IV hypertensive retinopathy (Keith, Wagener, Barker classification: grade III, narrowing of retinal arterioles, arteriovenous nip ping, cotton wool spots, haemorrhages, exudates, retinal oedema; grade IV, the same changes plus disc swelling) in combination with hypertension and proteinuria. In the majority the blood pressure was greater than 200/140 mmHg. An exact level of blood pressure is not required for the diagnosis of accelerated hypertension. n All had a clinical ocular examination at presentation, including pupil dilation as well as systemic examination and investigations, including urea and electrolytes, creatinine. chest radiograph and electrocardiogram (all were exam ined by the authors). Patients with ocular or neurological abnormalities not related to hyperten sion were excluded. All the patients had repeat clinical examinations at follow-up.
Twelve of the patients had electrophysiological and visual field measurements within a few days of their acute presentation. Seven of these were followed up for up to 6 months with repeat measurements. Twenty-two of the patients had electrophysiological and visual field measurements only 2-4 years after their initial presentation, but not at acute presentation.
The information recorded was: best corrected visual acuity; fundal appearance (this was documen ted by grading with the Keith, Wagener, Barker classification in both the acute and treated patients, plus by other features, such as optic atrophy, being recorded); Goldmann visual fields; pattern visual evoked potentials (VEP); flash electroretinograms (ERG). As this study was carried out over an 8 year period, only two of the more recently performed tests included pattern electroretinograms (PERG). The YEP and ERG results were compared with 20 randomly selected controls. These were age-and sex matched normotensive, normal subjects with no neurological or ophthalmic abnormality, selected from the electrophysiological department's control data base (mean age 43.8 years; 10 male, 10 female).
VEPs were obtained using a Nicolet C4 clinical averager. The stimulus consisted of a black and white checkerboard of 100% contrast reversing at 1.9 Hz. The stimulus field was 14 degrees, and the check size was 50 minutes of arc subtended at the eye. A Ag/ AgCI electrode was located at positions Fz (10/20 montage system) and referred to Ag/AgCI electrodes positioned at 01 and 02. The amplifier band-pass filter was set at 1-50 Hz and artefact rejection was set at 100 f.1 V. No notch filtering was employed. For each recording sequence 40 averages were obtained, and this was repeated two times for responses falling within the normal range of amplitude and latency, and three times for abnormal responses.
The presence of PNP wave forms in pattern VEPs of patients with anterior ischaemic optic neuropathy (AI ON) has been previously described by Thompson et al., 22 where the PIOO macular response is replaced by a P135 paramacular response leaving a negative component at approximately 100 ms. In Thompson's study all these VEPs were of low amplitude. To identify this wave form in our study we looked for a reproducible, low-amplitude positive-negative-posi tive response with the dominant positive at > 122 ms preceded by a consistent clearly defined negative component at ?100 ms. VEPs of normal amplitude but delayed without this positive-negative-positive wave form were considered to be a delayed P100 (see Figs. 1, 2).
ERGs were performed using Burian-Allen contact lens electrodes referred to the outer canthi of each eye. Scotopic responses were tested using a Ganzfield stimulus of 28 Foot Lamberts after 20 minutes of dark adaptation. Photopic responses were obtained with 30 Foot Lambert background illumi nation and 28 Foot Lambert stimulus intensity. Thirty-hertz cone responses were obtained using an intensity of 4 Foot Lamberts against a background of 10 Foot Lamberts. Responses were obtained using a Nicolet CA1000 clinical averager. Frequency band pass filtering was set at 1-1000 Hz, except when recording oscillatory potentials, when the band-pass was set at 100-1000 Hz. Three averages were obtained for scotopic stimuli and 20 for photopic and 30 Hz stimuli.
As this was a study over 8 years, only two of the more recently examined patients had PERGs. These were recorded using gold foil electrodes referred to the ipsilateral outer canthus. The stimulus consisted of a 50 minute checkerboard reversing at 5.9 Hz. The responses were averaged 150 times and repeated three times, using an artefact rejection of 50 f.1 V and a band-pass of 1-100 Hz.
Statistical analysis of results was done using the paired t-test for comparisons of findings in those patients assessed both acutely and at 6 month follow up (n = 7) and using analysis of variance with Bonferroni's procedure for comparisons of findings between controls, acute patients and long-term post acute patients without acute data. Figures from individual eyes were used for calculations.
RESULTS

Visual Acuity
At presentation 22 eyes (22/68, 32 %) had a best corrected visual acuity of �6/12. At follow-up 10 eyes (10/58, 17%) had visual acuities of �6/12. The separate figures for the patients seen at 6 month follow-up and those with 2-4 years of follow-up are given in Table I . The long-term causes of decreased visual acuity were: anterior ischaemic opti� neuro pathy (3), including one which developed after starting treatment), continuing macular exudates (4), branch vein occlusion (1), cataract (1) and atrophic depigmented area of macula (1).
Fundal Appearance
At presentation 34 eyes (34/68, 50%) had grade IV retinopathy and 34 had grade III. At follow-up (those seen at 6 months and those seen at 2-4 years), no eyes had grade IV retinopathy, 9 eyes (9/58, 15.5%) had grade III, 38 (65.5%) had grade II and 11 (19%) had grade 1. Exudates were present in 6 eyes of those with grade III retinopathy; cotton wool spots and small retinal haemorrhages were present in 3. Other findings were optic atrophy (3), branch retinal vein occlusion (1) and areas of depigmented retina (6) . No fundi could be classified as normal, i.e. without a hypertensive grading. Separate figures for the 7 patients seen acutely and followed up at 6 months are given in Table II . 
Visual Fields
In the acute group visual field abnormalities occurred in 10 of the 12 patients (18 eyes, 75%). These defects were: altitudinal (9 eyes), enlarged blind spots (10 eyes), arcuate scotomas (7 eyes) and centrocaecal scotoma (8 eyes) (some eyes had more than one pattern of field defect). In the 7 patients followed up. 6 patients (10 eyes) still had field defects of which 6 eyes were improved but only 2 to within normal limits (Table II) . Of the 22 patients assessed after 2-4 years, field defects were found in 5 patients (7 eyes, 16%). The 3 patients with optic atrophy all had inferior altitudinal defects, but 1 also had an enlarged blind spot and an accurate defect.
ERG
All 12 of the patients measured acutely had abnormalities of the ERG compared with controls (Table III) In the 7 patients who were followed up within 6 months of the acute episode there was no significant difference in the mean ERG amplitude and latency compared with the acute recordings (Tables II, IV) , none of the ERGs having changed significantly in any of the patients.
In the group assessed after 2-4 years ERG b wave abnormalities occurred in 18 of 22 patients (75%), all 18 having at least a unilateral delay of the scotopic (23 eyes), photopic (24 eyes) and cone (30 Hz) responses (28 eyes), with 6 of these (8 eyes) also having a reduction in amplitude of the cone (30 Hz) response and 3 (3 eyes) a reduction in amplitude of the scotopic b wave. Oscillatory potentials were reduced in 26 eyes (Table V) . One patient had a reduction of the scotopic b wave >2.5 standard deviations below the absolute limits of normal.
In the 2 patients measured acutely who underwent PERG, N95 was reduced in both (3 eyes) and P50 was reduced in one (1 eye). The P50/N95 ratio was abnormally high in the 3 eyes with reduced N95. In Table III both patients the PERG abnormality was associated with an abnormal YEP, and in one eye the ERG was normal.
VEP
Of the 12 patients measured acutely, 11 (92%) (171 24,70% eyes) had abnormal pattern VEPs, 10 (83%) (14/24,58% eyes) exhibiting reductions in amplitude, and in 15 eyes (62.5%) of 9 of these patients the VEPs were delayed beyond the normal limit of PlOO latency of 122 ms (normal limit for this laboratory). In 5 cases these changes were unilateral, correlating with the severity or presence of disc swelling. The group mean latency of the PlOO component in all 24 eyes was 128.9 ms. The group mean amplitude was 4.1 J.1 V. Of the 7 patients followed up, 6 eyes had a delay of the PlOO beyond 122 ms (group mean 123.8 IDS) during the acute phase; 4 recovered to within normal limits (group mean 110.9 ms), demonstrating significant improvement (p<0.005). In this group of 7 patients the amplitude was reduced in 9 eyes acutely (group mean 3.3 J.1 V). In 6 this significantly recovered (group mean 4.9 J.1 V) (p<0.025). A bifid (PNP) wave form (P135) occurred in 13 of the 24 eyes seen acutely (Figs. 1,2) ; 8 of these were in the 7 patients (14 eyes) followed up. At follow-up the pattern of response had returned to normal in 6 of these 8 eyes. In the group measured at 2-4 years only 2 VEPs were abnormal (2 eyes; 2/44, 0.045%), 1 reduced and delayed, 1 reduced only (group mean latency 109.1 ms), which was significantly different from the patients measured acutely (p<0.005). The group mean P100 amplitude was 7.2 J.1 V, which was significantly greater than that measured acutely (p<O.005). Three of the 12 patients measured acutely, with unilateral ERG abnormalities and unilateral YEP abnormalities, exhibited YEP abnormalities in the eye with a normal ERG (Figs. 3, 4) . In 6 cases, renal disease was found to be the cause of the accelerated hypertension. In 22 of 28 (78%) the creatinine concentration was found to be higher than normal (>120 mmolll) at presentation. One patient had toxaemia of pregnancy. The remainder (27) were classified as essential hypertension. In the group followed up for 2-4 years after presentation 11 of 22 (50%) still had diastolic blood pressures �100 mmHg. This is despite extensive efforts at treatment. These included 3 of the patients with continued macular exudates. Chest radiographs showed left ventricular hypertrophy in 11 of 28 (39%) cases. Electrocardiograms showed left ventricular hyper trophy in 13 of 27 (48 %) cases and evidence of ischaemic heart disease in 14 of 27 (52 %) cases. During follow-up an additional 4 patients suffered from renal disease, 8 from symptoms of ischaemic heart disease, and 4 had a cerebrovascular event.
DISCUSSION
Accelerated hypertension can affect the fundus in three main ways: by causing a retinopathy, choroido pathy and an optic neuropathy. 19 . 20 The clinical presentation of these features varies greatly from patient to patient, presumably reflecting such factors as the severity of the hypertension, varying ability to resist its effects and the speed of onset of the hypertension, as well as coexistent disease such as diabetes. For example, hypertensive retinopathy occurs earlier than choroidopathy or optic neuro pathy. 2o Choroidopathy tends to occur in the relatively young, especially with acute hypertension -for example, in toxaemia of pregnancy. 2 3 Whether visual acuity will be reduced depends on whether the macular or optic nerve function is affected. Florid cases can have surprisingly good Fig. 4 . This was normal in the left eye but abnormal in the right. The patient was not followed up.
vision, though, as can be seen from our results, several did have reduced visual acuity at initial presentation (22/68, 32% of eyes). The severity of these changes were usually asymmetric. The visual acuity remained reduced in 7 of 44 (16%) eyes seen 2-4 years after the acute episode.
The ERG was at least unilaterally abnormal in all the cases measured acutely. The abnormal Ganzfeld ERG recordings suggest widespread retinal damage. However, none of the ERGs was severely reduced and changes mainly affected the cone system. The ERG remained abnormal in all these cases and in 82 % of the cases seen between 2 and 4 years after the acute episode. This is despite resolution of the majority of the fundal signs. This is not surprising considering that some of the features of the retino pathy and choroidopathy may involve infarction of tissue.
The pattern YEP was abnormal in the majority of the acute cases studied (920ft»), being delayed in 15 eyes (62.5%) and with 14 eyes (58%) having a decrease in amplitude. It is difficult to ascertain how much of this was due to macular pathology as opposed to decreased optic nerve function. Most of the patients underwent electrophysiological testin� before PERG was available in our laboratory. 4 Clinically both the macula and the optic nerve are affected in accelerated hypertension. We would argue, however, that a major factor is optic nerve ischaemia. In the 2 patients who underwent PERG the P50/N95 ratio was higher than normal, implying an optic neuropathy rather than maculopathy, although P50 was reduced in one eye suggesting some macular involvement. It was also notable that in 3 patients with unilateral ERG and YEP abnormalities the YEP was abnormal, with a PNP appearance in the eye with the normal ERG. A PNP wave form, previously described with AION (see Methods), was seen in 16 of 24 eyes seen acutely.
The 3 patients with optic atrophy had altitudinal defects compatible with the diagnosis of AION. Many of the other field defects were also compatible with a decrease in optic nerve function. However, the optic disc pallor may have reflected either retinal nerve fibre and ganglion cell loss in the retina, or primary optic disc damage at the retrolaminar level.
Pathologically optic disc oedema represents nerve fibre swelling and is thought to occur due to ischaemia interfering with axoplasmic flow in the nerve head. 2 s Hayreh et al., 2 1 in their experiments on rhesus monkeys, concluded that optic disc oedema in accelerated hypertension represents an ischaemic optic neuropathy. Unlike the ERG recordings, the YEP tends to return to normal in line with the resolution of the disc swelling. This could suggest reversibility of the ischaemic optic neuropathy, although in 3 cases severe optic atrophy remained. Reversible optic disc ischaemia has been noted before, as it is thought to occur in young diabetics who develop transient optic disc oedema. Non-arteritic AION usually does not occur in the context of accelerated hypertension, but rather in patients with diabetes or atherosclerosis?fJ though hypertension has been associated as a risk factor in some studiesP Some authors argue that certain cases of ischaemic optic neuropathy may be specifically due to hypertensive optic nerve infarction. 2 8 This paper supports the theory that hypertension can cause anterior ischaemic optic neuropathy.
In conclusion we suggest that during the acute stage of accelerated hypertension there is a high incidence of ischaemic optic neuropathy which usually resolves, but in a few cases AION ensues. This was the cause for the poorest visual outcome. Permanent retinal damage is also evident.
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